Literature DB >> 27702899

Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease.

Xiuming Zhang1, Elizabeth C Mormino2, Nanbo Sun1, Reisa A Sperling2, Mert R Sabuncu3, B T Thomas Yeo4.   

Abstract

We used a data-driven Bayesian model to automatically identify distinct latent factors of overlapping atrophy patterns from voxelwise structural MRIs of late-onset Alzheimer's disease (AD) dementia patients. Our approach estimated the extent to which multiple distinct atrophy patterns were expressed within each participant rather than assuming that each participant expressed a single atrophy factor. The model revealed a temporal atrophy factor (medial temporal cortex, hippocampus, and amygdala), a subcortical atrophy factor (striatum, thalamus, and cerebellum), and a cortical atrophy factor (frontal, parietal, lateral temporal, and lateral occipital cortices). To explore the influence of each factor in early AD, atrophy factor compositions were inferred in beta-amyloid-positive (Aβ+) mild cognitively impaired (MCI) and cognitively normal (CN) participants. All three factors were associated with memory decline across the entire clinical spectrum, whereas the cortical factor was associated with executive function decline in Aβ+ MCI participants and AD dementia patients. Direct comparison between factors revealed that the temporal factor showed the strongest association with memory, whereas the cortical factor showed the strongest association with executive function. The subcortical factor was associated with the slowest decline for both memory and executive function compared with temporal and cortical factors. These results suggest that distinct patterns of atrophy influence decline across different cognitive domains. Quantification of this heterogeneity may enable the computation of individual-level predictions relevant for disease monitoring and customized therapies. Factor compositions of participants and code used in this article are publicly available for future research.

Entities:  

Keywords:  Alzheimer’s disease heterogeneity; Alzheimer’s disease subtypes; mental disorder subtypes; unsupervised machine learning; voxel-based morphometry

Mesh:

Year:  2016        PMID: 27702899      PMCID: PMC5081632          DOI: 10.1073/pnas.1611073113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.

Authors:  Laura E Gibbons; Adam C Carle; R Scott Mackin; Danielle Harvey; Shubhabrata Mukherjee; Philip Insel; S McKay Curtis; Dan Mungas; Paul K Crane
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

Review 3.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

Review 4.  Neuropsychological assessment of dementia.

Authors:  David P Salmon; Mark W Bondi
Journal:  Annu Rev Psychol       Date:  2009       Impact factor: 24.137

5.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

6.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

7.  Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Authors:  Victor L Villemagne; Samantha Burnham; Pierrick Bourgeat; Belinda Brown; Kathryn A Ellis; Olivier Salvado; Cassandra Szoeke; S Lance Macaulay; Ralph Martins; Paul Maruff; David Ames; Christopher C Rowe; Colin L Masters
Journal:  Lancet Neurol       Date:  2013-03-08       Impact factor: 44.182

8.  Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI.

Authors:  Val J Lowe; Patrick J Peller; Stephen D Weigand; Catalina Montoya Quintero; Nirubol Tosakulwong; Prashanthi Vemuri; Matthew L Senjem; Lennon Jordan; Clifford R Jack; David Knopman; Ronald C Petersen
Journal:  Neurology       Date:  2013-05-03       Impact factor: 9.910

9.  Hierarchical modularity in human brain functional networks.

Authors:  David Meunier; Renaud Lambiotte; Alex Fornito; Karen D Ersche; Edward T Bullmore
Journal:  Front Neuroinform       Date:  2009-10-30       Impact factor: 4.081

10.  Gray and white matter distribution in dyslexia: a VBM study of superior temporal gyrus asymmetry.

Authors:  Marjorie Dole; Fanny Meunier; Michel Hoen
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

View more
  61 in total

Review 1.  [Big data approaches in psychiatry: examples in depression research].

Authors:  D Bzdok; T M Karrer; U Habel; F Schneider
Journal:  Nervenarzt       Date:  2018-08       Impact factor: 1.214

2.  Multimodal Parcellations and Extensive Behavioral Profiling Tackling the Hippocampus Gradient.

Authors:  Anna Plachti; Simon B Eickhoff; Felix Hoffstaedter; Kaustubh R Patil; Angela R Laird; Peter T Fox; Katrin Amunts; Sarah Genon
Journal:  Cereb Cortex       Date:  2019-12-17       Impact factor: 5.357

3.  Computing Univariate Neurodegenerative Biomarkers with Volumetric Optimal Transportation: A Pilot Study.

Authors:  Yanshuai Tu; Liang Mi; Wen Zhang; Haomeng Zhang; Junwei Zhang; Yonghui Fan; Dhruman Goradia; Kewei Chen; Richard J Caselli; Eric M Reiman; Xianfeng Gu; Yalin Wang
Journal:  Neuroinformatics       Date:  2020-10

4.  B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized FAVORIT Ancillary Cognitive Trial.

Authors:  T M Scott; G Rogers; D E Weiner; K Livingston; J Selhub; P F Jacques; I H Rosenberg; A M Troen
Journal:  J Prev Alzheimers Dis       Date:  2017

Review 5.  A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.

Authors:  AmanPreet Badhwar; G Peggy McFall; Shraddha Sapkota; Sandra E Black; Howard Chertkow; Simon Duchesne; Mario Masellis; Liang Li; Roger A Dixon; Pierre Bellec
Journal:  Brain       Date:  2020-05-01       Impact factor: 13.501

6.  Spatial Topography of Individual-Specific Cortical Networks Predicts Human Cognition, Personality, and Emotion.

Authors:  Ru Kong; Jingwei Li; Csaba Orban; Mert R Sabuncu; Hesheng Liu; Alexander Schaefer; Nanbo Sun; Xi-Nian Zuo; Avram J Holmes; Simon B Eickhoff; B T Thomas Yeo
Journal:  Cereb Cortex       Date:  2019-06-01       Impact factor: 5.357

Review 7.  Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease.

Authors:  Elizabeth C Mormino; Kathryn V Papp
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline.

Authors:  Mara Ten Kate; Ellen Dicks; Pieter Jelle Visser; Wiesje M van der Flier; Charlotte E Teunissen; Frederik Barkhof; Philip Scheltens; Betty M Tijms
Journal:  Brain       Date:  2018-12-01       Impact factor: 13.501

Review 9.  Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods.

Authors:  Mohamad Habes; Michel J Grothe; Birkan Tunc; Corey McMillan; David A Wolk; Christos Davatzikos
Journal:  Biol Psychiatry       Date:  2020-01-31       Impact factor: 13.382

10.  Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET.

Authors:  Renaud La Joie; Adrienne V Visani; Suzanne L Baker; Jesse A Brown; Viktoriya Bourakova; Jungho Cha; Kiran Chaudhary; Lauren Edwards; Leonardo Iaccarino; Mustafa Janabi; Orit H Lesman-Segev; Zachary A Miller; David C Perry; James P O'Neil; Julie Pham; Julio C Rojas; Howard J Rosen; William W Seeley; Richard M Tsai; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Sci Transl Med       Date:  2020-01-01       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.